UA85608C2 - Противомикробная композиция для перорального введения c лактулозой - Google Patents

Противомикробная композиция для перорального введения c лактулозой

Info

Publication number
UA85608C2
UA85608C2 UAA200702431A UAA200702431A UA85608C2 UA 85608 C2 UA85608 C2 UA 85608C2 UA A200702431 A UAA200702431 A UA A200702431A UA A200702431 A UAA200702431 A UA A200702431A UA 85608 C2 UA85608 C2 UA 85608C2
Authority
UA
Ukraine
Prior art keywords
oral administration
antimicrobial composition
composition
lactulose
antibiotic
Prior art date
Application number
UAA200702431A
Other languages
English (en)
Ukrainian (uk)
Inventor
Николай Александрович Киселёв
Дмитрий Сергеевич Чичерин
Original Assignee
Николай Александрович Киселёв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA85608(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Николай Александрович Киселёв filed Critical Николай Александрович Киселёв
Publication of UA85608C2 publication Critical patent/UA85608C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области медицины и химико-фармацевтической промышленности, в частности к лекарственным формам антибиотиков. Противомикробная композиция содержит антибиотик, выбранный из группы линкозамидов, пенициллинов широкого спектра действия, цефалоспоринов, макролидов, тетрациклинов, и лактулозу при соотношении активных компонентов 1:1-1:100. Средний размер частиц лактулозы составляет 100 нм - 200 мкм. Возможно выполнение композиции в твердой форме и в форме сиропа или суспензии. При необходимости в композицию могут быть введены фармацевтически приемлемые эксципиенты для придания приемлемой для перорального применения формы.
UAA200702431A 2004-08-30 2005-08-25 Противомикробная композиция для перорального введения c лактулозой UA85608C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения

Publications (1)

Publication Number Publication Date
UA85608C2 true UA85608C2 (ru) 2009-02-10

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200702431A UA85608C2 (ru) 2004-08-30 2005-08-25 Противомикробная композиция для перорального введения c лактулозой

Country Status (21)

Country Link
US (1) US8231871B2 (ru)
EP (1) EP1790357B1 (ru)
JP (1) JP5062480B2 (ru)
CN (1) CN101031321B (ru)
AT (1) ATE410185T1 (ru)
AU (1) AU2005280704B2 (ru)
BR (1) BRPI0514708A (ru)
CA (1) CA2620919C (ru)
DE (1) DE602005010280D1 (ru)
DK (1) DK1790357T3 (ru)
EA (1) EA010199B1 (ru)
ES (1) ES2314708T3 (ru)
MX (1) MX2007002291A (ru)
NZ (1) NZ554212A (ru)
PL (1) PL1790357T3 (ru)
PT (1) PT1790357E (ru)
RU (1) RU2284832C2 (ru)
TR (1) TR200703565T1 (ru)
UA (1) UA85608C2 (ru)
WO (1) WO2006025767A2 (ru)
ZA (1) ZA200704449B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103040773A (zh) 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии
RU2325166C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и лактулозы для профилактики энтеральных дисбиозов в процессе антибиотикотерапии
WO2009116886A1 (ru) 2008-03-18 2009-09-24 Dikovskiy Aleksander Vladimiro Фармацевтическая композиция и способ профилактики дисбиозов, ассоциированных с энтеральным приемом антибиотиков
PT2266581E (pt) 2008-03-18 2016-01-27 Aleksander Vladimirovich Dikovskiy Composição farmacológica de antibióticos e prebióticos para prevenir e tratar disbiose durante terapia antibacteriana
RU2415684C2 (ru) * 2008-04-16 2011-04-10 Александр Владимирович Диковский Фармацевтическая композиция для лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц и способ лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц
CA2911303C (en) 2013-05-07 2021-02-16 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
DE3577656D1 (de) * 1984-07-23 1990-06-21 Lilly Co Eli Pharmazeutische zusammensetzungen von ceftazidim.
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
NZ228342A (en) * 1988-03-18 1991-03-26 Duphar Int Res Preparing solid form of lactulose from lactulose syrup
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
ES2188657T3 (es) * 1994-04-22 2003-07-01 Yamanouchi Pharma Co Ltd Sistema para la liberacion especifica en el colon de un farmaco.
DE59702733D1 (de) * 1996-08-15 2001-01-11 Losan Pharma Gmbh Gut schluckbare orale arzneiform
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
KR20020003864A (ko) * 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
AU5108200A (en) * 1999-06-09 2000-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract

Also Published As

Publication number Publication date
WO2006025767A2 (fr) 2006-03-09
WO2006025767A3 (fr) 2006-08-17
US8231871B2 (en) 2012-07-31
DE602005010280D1 (de) 2008-11-20
WO2006025767A8 (en) 2007-04-05
EA200700357A1 (ru) 2008-06-30
PL1790357T3 (pl) 2009-03-31
CN101031321A (zh) 2007-09-05
MX2007002291A (es) 2008-02-12
PT1790357E (pt) 2008-12-31
EA010199B1 (ru) 2008-06-30
CA2620919A1 (en) 2006-03-09
JP2008511622A (ja) 2008-04-17
EP1790357A4 (en) 2007-11-07
NZ554212A (en) 2009-08-28
AU2005280704A1 (en) 2006-03-09
TR200703565T1 (tr) 2007-08-21
CA2620919C (en) 2014-10-14
ES2314708T3 (es) 2009-03-16
EP1790357B1 (en) 2008-10-08
RU2284832C2 (ru) 2006-10-10
JP5062480B2 (ja) 2012-10-31
US20070254023A1 (en) 2007-11-01
ATE410185T1 (de) 2008-10-15
EP1790357A2 (en) 2007-05-30
RU2004126203A (ru) 2006-02-10
CN101031321B (zh) 2010-12-15
DK1790357T3 (da) 2009-02-02
ZA200704449B (en) 2008-08-27
BRPI0514708A (pt) 2008-06-24
AU2005280704B2 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
ZA200704449B (en) Perorally administrable antimicrobial composition
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
WO2004087043A3 (en) Stable ophthalmic formulation containing an antibiotic and a corticosteroid
WO2004103311A3 (en) Antibiotic composition
WO2003028696A8 (en) Compositions for delivery of drug combinations
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
WO2008039406A3 (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
WO2007116102A3 (en) Therapeutic composition and use
MX2007007235A (es) Combinacion de antibioticos para proporcionar una solucion total al tratamiento de infecciones.
Zanetti et al. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections
WO2005117895A3 (en) Compositions comprising meloxicam
WO2009083211A3 (de) Pharmazeutische zusammensetzung zur prophylaxe und/oder symptomatischen behandlung von zystischer fibrose
TW200602090A (en) Antibiotic-based pharmaceutical formulation in microcapsular form
WO2003075852A3 (en) Antibiotic composition
CA2502582A1 (en) Pharmaceutical formulation of olanzapine
BR0117171A (pt) Composição farmacêutica para liberação controlada de um antibiótico do tipo beta-lactama
WO2007011958A3 (en) Intraoral dosage forms of glucagon
WO2003101405A3 (en) Aminoglycoside antibiotics and methods of using same
WO2005065685A8 (en) Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
Piyasirisilp et al. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital
File Jr The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults
CA2547866A1 (en) Farnesyl dibenzodiazepinone formulation
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
PL379703A1 (pl) Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania